Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Georg Thieme Verlag KG
2023-07-01
|
| Series: | TH Open |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-2122-7887 |
| _version_ | 1797734692770807808 |
|---|---|
| author | Naoki Matsumoto Hiroto Abe Ryohei Kawasaki Yoshihito Tashiro Mariko Noguchi-Sasaki Suguru Harada Koichiro Yoneyama Tomomi Niino Tetsuhiro Soeda Yasushi Yoshimura |
| author_facet | Naoki Matsumoto Hiroto Abe Ryohei Kawasaki Yoshihito Tashiro Mariko Noguchi-Sasaki Suguru Harada Koichiro Yoneyama Tomomi Niino Tetsuhiro Soeda Yasushi Yoshimura |
| author_sort | Naoki Matsumoto |
| collection | DOAJ |
| first_indexed | 2024-03-12T12:47:04Z |
| format | Article |
| id | doaj.art-12ff278caee346a7a9c631bc8db8a400 |
| institution | Directory Open Access Journal |
| issn | 2512-9465 |
| language | English |
| last_indexed | 2024-03-12T12:47:04Z |
| publishDate | 2023-07-01 |
| publisher | Georg Thieme Verlag KG |
| record_format | Article |
| series | TH Open |
| spelling | doaj.art-12ff278caee346a7a9c631bc8db8a4002023-08-28T23:13:24ZengGeorg Thieme Verlag KGTH Open2512-94652023-07-010703e241e24310.1055/a-2122-7887Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in JapanNaoki Matsumoto0https://orcid.org/0000-0002-0817-596XHiroto Abe1Ryohei Kawasaki2Yoshihito Tashiro3Mariko Noguchi-Sasaki4https://orcid.org/0000-0002-4703-2080Suguru Harada5Koichiro Yoneyama6Tomomi Niino7Tetsuhiro Soeda8Yasushi Yoshimura9Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, JapanChugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, JapanChugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, JapanChugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, JapanChugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, JapanChugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, JapanChugai Pharmaceutical Co., Ltd., Chuo-ku, Tokyo, JapanChugai Pharmaceutical Co., Ltd., Chuo-ku, Tokyo, JapanChugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, JapanChugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japanhttp://www.thieme-connect.de/DOI/DOI?10.1055/a-2122-7887 |
| spellingShingle | Naoki Matsumoto Hiroto Abe Ryohei Kawasaki Yoshihito Tashiro Mariko Noguchi-Sasaki Suguru Harada Koichiro Yoneyama Tomomi Niino Tetsuhiro Soeda Yasushi Yoshimura Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan TH Open |
| title | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_full | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_fullStr | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_full_unstemmed | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_short | Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan |
| title_sort | characterization of anti emicizumab antibodies using repository samples obtained in clinical studies of emicizumab conducted in japan |
| url | http://www.thieme-connect.de/DOI/DOI?10.1055/a-2122-7887 |
| work_keys_str_mv | AT naokimatsumoto characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT hirotoabe characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT ryoheikawasaki characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT yoshihitotashiro characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT marikonoguchisasaki characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT suguruharada characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT koichiroyoneyama characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT tomominiino characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT tetsuhirosoeda characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan AT yasushiyoshimura characterizationofantiemicizumabantibodiesusingrepositorysamplesobtainedinclinicalstudiesofemicizumabconductedinjapan |